IQVIAIQVEarnings & Financial Report
IQVIA Holdings, Inc., headquartered in Durham, North Carolina, is an American company focused on health information technology and clinical research.
IQV Q4 2025 Key Financial Metrics
売上高
$4.4B
粗利益
N/A
営業利益
$627.0M
純利益
$514.0M
粗利益率
N/A
営業利益率
14.4%
純利益率
11.8%
前年比成長
10.3%
EPS
$2.97
資金フロー
IQVIA Q4 2025 Financial Summary
IQVIA reported revenue of $4.4B for Q4 2025, with a net profit of $514.0M (11.8% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $4.4B |
|---|---|
| Net Profit | $514.0M |
| Gross Margin | N/A |
| Operating Margin | 14.4% |
| Report Period | Q4 2025 |
IQVIA Annual Revenue by Year
IQVIA annual revenue history includes year-by-year totals (for example, 2025 revenue was $16.3B).
| Year | Annual Revenue |
|---|---|
| 2025 | $16.3B |
| 2024 | $15.4B |
| 2023 | $15.0B |
| 2022 | $14.4B |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $3.74B | $3.81B | $3.90B | $3.96B | $3.83B | $4.02B | $4.10B | $4.36B |
| 前年比成長 | 2.3% | 2.3% | 4.3% | 2.3% | 2.5% | 5.3% | 5.2% | 10.3% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $26.57B | $26.40B | $27.18B | $26.90B | $27.32B | $28.63B | $28.73B | $29.94B |
| 総負債 | $20.23B | $19.68B | $20.21B | $20.83B | $21.34B | $22.85B | $22.44B | $23.31B |
| 株主資本 | $6.34B | $6.71B | $6.97B | $6.07B | $5.98B | $5.78B | $6.16B | $6.50B |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $522.0M | $588.0M | $721.0M | $885.0M | $568.0M | $443.0M | $908.0M | $735.0M |
Other Health Care Companies
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
TECH
Bio-Techne
売上高
$295.9M
純利益
$38.0M
CRL
Charles River Laboratories
売上高
$994.2M
純利益
$-276.6M
DHR
Danaher Corporation
売上高
$6.1B
純利益
$908.0M
MTD
Mettler Toledo
売上高
$1.1B
純利益
$285.8M
TMO
Thermo Fisher Scientific
売上高
$11.1B
純利益
$1.6B
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B